Eficacia de la reconciliación de medicamentos en la prevención de eventos adversos.

Recent studies support medication reconciliation (MR) as an imegral step in the process ofcare andas an importam initiativefor the patient's safety. Despite this, these results have not been sufficiently evaluated. OBJECTIVE: to determine whether the reconciliation procedure is effective in the prevention ofmedication errors audlor to improve the outcome ofhealth care. Methodology: searchers were carried out in differem electronic databases (MEDLINE, EMBASE, Scielo, Cochrane) and grey literature bases. Controlled and Randomised Clinical Trials (CCTs and CRTs) were selected and in their absence, other research designs (non randomised clinical trials or quasi-experimental studies) were selected. The participants were subjectsfrom all age groups, Thefollowing results were included: rehospitalisations, visits to the ER, adverse events to drugs and mortality. Two foreign reviewers extracted the data and independently evaluated the quality ofthe studies using the Jadad scale. RESULTS: 163 articles were located audfour were included to conduct the meta-analysis. The total number ofpatients was 1259. MR significamly reduced the number ofvisits to the ER: (odds ratio 0,66; 95% C1: 0,480,90) and rehospitalisation rates: (odds ratio 0,87; 95% 0: 0,63-1,19). CONCLUSIONS: MR is effective in reducing the rate ofadverse events caused by medication errors and the rate ofvisits to the ER and hospitaUsations.